Member Info for Lottohopes

I was looking for youtube videos of Frank McAllister. My fear was: is this some guy who is over the hill (over 50 years of experience in the sector!!). I couldn't be more wrong. He's razor sharp in interviews, and looks like he knows his sector. I always look for people to invest in, as much as the resource/s. The team is looking formidable, so very happy to wait. Found some change so topped up again. Good luck all

Just listened to the podcast. I like the fact DL talks about small companies and Abt producing....doesn't sound like just another junior explorer.....interesting weeks ahead.

itsagame: I reckon its an oversight....although I do love conspiracy theories

Interesting, uranium..... Exciting weeks ahead

Back of sofa change £150 top up....that's it, I havent a penny left now

Morning folks: Any comments on the chart TA wise?

Morning folks, had a small £750 top up, at 2.7p. Bargain imho

The RNS released on 26th Jan mentioning a change in advisor, mentions "new" board in a few places. That suggests our new CEO was on board, as Screech suggested.

Some confusion in my head ant the RTO time frame. Link posted by Screech below states June 2017 (6 months from Dec) But the recent RNS accompanying acquisitions states 6 months period from Jan 2017 "Consequently, China Africa continues to be required to complete a reverse takeover within six months of 11 January 2017 or face suspension from trading on AIM." What do people reckon?

Hi Okenia: thank you for the additional info. I watched a video interview of David's, from last year, it was discussing the mining sector. He's never headed a mining company before, so he will be keen to prove he can do the job. Also he stated his firm (BD) was most active in the continent of Africa. In other words, good networks and awareness of region. It's turned more exciting for me atleast....

Draft: I know the question wasn't aimed at me, but why is it getting tight? 6 months from Jan is July....

https://www.brrmedia.co.uk/broadcasts/577e1b97be9f172560a20e27/behre-dolbear-company-overview Not sure if this was posted today. For me, seeing the person speaking, gives me something more than just reading their cv. Very sharp and competent sounding chap. David stepped down from his Associate role at BD, on 24th Jan. That tells me, this change was all strategically planned and orchestrated. Just my humble opinion.

I am delighted to assume the position of CEO at China Africa.� I have been closely involved in the mineral sector for many years, a significant portion of which has been spent in fund management financing resource companies. Through this network I will also seek to support our future work with a pool of high quality capital from well-regarded institutions, hedge funds and family offices known to myself and my team. Could he be any clearer in intentions? Money is coming in

Screech: I m pleased for you. Good decision to stay on my instinct says. Thank you to the posts describing BD: it's a much larger more influential firm than PJ. IMHO

I've emailed the company asking for details of the projects such as size, location map etc. I'll post if I get a response.

Worth noting that 1 unit of elemental Li is equal to 2.153 units of Lithium Dioxide. (given BGS, KOD etc report as lithium dioxide equivalents). Grades are very nice......thanks Screech for pointing this one to me!

Thanks Screech 👍

This is very strange. I posted few days ago asking if folks had looked at this company with whom we are colloborating (supplying lentiviral material). But the post has disappeared! Anyways I was saying OXB seems to have its hands in many pies and although the royalties here are only 1.95% times two, we need just one colloborator to hit jackpot and we are on our way.

Jack:.you and I are both partly correct. The team was disbanded, and 120 jobs went, the head of the program left. The rest were redeployed/absorbed into existing teams. The language used in the article below doesn't suggest re-integration, it suggests staff being let go. We can agree to disagree. https://endpts.com/novartis-car-t-chief-azam-is-leaving-but-pharma-giant-denies-any-retreat-is-underway/ In any case, I wasn't suggesting Novartis interest in CART treatments has dwindled, far from it given they have the first mover advantage. Frankly I don't understand it all either, it's a complex space. Wait and see Q1 17 I guess.....

I was trying to read on CART and the market, given our hopes of revenue stem from here. Three companies competing in the CART space, for haematological cancers: Novartis (which leads), Kite and Juno. Novartis closed its own team which was researching the gene cell therapies, so unlikely to ramp up GMP manufacturing. Kite has a state of the art facility in the U.S., AND has collaborated with GE to try to automate the manufacturing process. They started a year ago, but I can't find any updated info. Both Kite and Novartis intend to apply to FDA for quick licensing route in Q1 2017. http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=945374 One of our customers GSK too has formed an agreement with a German firm towards similar CART automation. If this happens, I guess it's bad news for human input intensive labs like ours which intend to supply big pharma with CART. BUT I don't see it happening any time soon given the level of expertise/skill needed. Indeed our invaluable input would be needed to build these automations. http://www.biopharma-reporter.com/Upstream-Processing/GSK-partners-with-Miltenyi-Biotec-to-target-CAR-T-therapy-automation So lots of unknowns, let's wait into Q1 17 and see what happens.